Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Infective endocarditis is defined by a focus of infection within the heart and is a feared disease
across the field of cardiology. It is frequently acquired in the health care setting, and more …

The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004.
The guidelines presented here have been updated and extended to reflect developments …

Background Valvular heart disease (VHD) is expected to become more common as the
population ages. However, current estimates of its natural history and prevalence are based on …

Background Aortic stenosis (AS) leads to diffuse fibrosis in the myocardium, which is linked
to adverse outcome. Myocardial T1 values change with tissue composition. Objective To test …

The role of surgery in active IE has expanded progressively since early reports of successful
outcome. 10 Subsequent declines in mortality may be attributed to a variety of …

Infections related to implantable cardiac electronic devices (ICEDs), including pacemakers,
implantable cardiac defibrillators and cardiac resynchronization therapy devices, are …

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus …

Infective endocarditis (IE) is an evolving disease with a persistently high mortality and
morbidity, even in the modern era of advanced diagnostic imaging, improved antimicrobial …